Stay updated with breaking news from Peter Greenleaf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Rating) (TSE:AUP) in a research report report published on Thursday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Royal Bank of Canada lifted their price objective on shares of Aurinia Pharmaceuticals from $11.00 to $13.00 and gave the company an […]
Aurinia Pharmaceuticals Inc. today announced voting results for its annual general meeting of shareholders held on May 17, 2023. Shareholders re-elected six of eight incumbent directors to the... | May 17, 2023
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) shares traded down 6.4% during trading on Tuesday . The stock traded as low as $10.09 and last traded at $10.18. 1,176,587 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 3,305,892 shares. The stock had previously closed at $10.88. […]
Nicolet Advisory Services LLC bought a new position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 18,297 shares of the biotechnology company’s stock, valued at approximately $152,000. Several […]
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Rating) (TSE:AUP) announced its quarterly earnings results on Thursday. The biotechnology company reported ($0.18) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.05, Briefing.com reports. Aurinia Pharmaceuticals had a negative net margin of 65.90% and a negative return on equity of 23.17%. The firm had revenue of […]